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Background: The development of novel biomaterials able to control cell activities and direct their fate is warranted
for engineering functional bone tissues. Adding bioactive materials can improve new bone formation and better
osseointegration. Three types of titanium (Ti) implants were tested for in vitro biocompatibility in this comparative
study: Ti6Al7Nb implants with 25% total porosity used as controls, implants infiltrated using a sol–gel method with
hydroxyapatite (Ti HA) and silicatitanate (Ti SiO2). The behavior of human osteoblasts was observed in terms of
adhesion, cell growth and differentiation.
Results: The two coating methods have provided different morphological and chemical properties (SEM and EDX
analysis). Cell attachment in the first hour was slower on the Ti HA scaffolds when compared to Ti SiO2 and porous
uncoated Ti implants. The Alamar blue test and the assessment of total protein content uncovered a peak of
metabolic activity at day 8–9 with an advantage for Ti SiO2 implants. Osteoblast differentiation and de novo
mineralization, evaluated by osteopontin (OP) expression (ELISA and immnocytochemistry), alkaline phosphatase
(ALP) activity, calcium deposition (alizarin red), collagen synthesis (SIRCOL test and immnocytochemical staining)
and osteocalcin (OC) expression, highlighted the higher osteoconductive ability of Ti HA implants. Higher soluble
collagen levels were found for cells cultured in simple osteogenic differentiation medium on control Ti and Ti SiO2
implants. Osteocalcin (OC), a marker of terminal osteoblastic differentiation, was most strongly expressed in
osteoblasts cultivated on Ti SiO2 implants.
Conclusions: The behavior of osteoblasts depends on the type of implant and culture conditions. Ti SiO2 scaffolds
sustain osteoblast adhesion and promote differentiation with increased collagen and non-collagenic proteins (OP
and OC) production. Ti HA implants have a lower ability to induce cell adhesion and proliferation but an increased
capacity to induce early mineralization. Addition of growth factors BMP-2 and TGFβ1 in differentiation medium did
not improve the mineralization process. Both types of infiltrates have their advantages and limitations, which can
be exploited depending on local conditions of bone lesions that have to be repaired. These limitations can also be
offset through methods of functionalization with biomolecules involved in osteogenesis.
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Current procedures to repair bone defects include the
use of grafts or implants, yet these approaches face import-
ant limitations. Bone tissue engineering has seen tremen-
dous development over the years, as much collaborative
effort of scientists, surgeons and engineers has been spent
to create bone implants and/or grafts which enhance bone
repair and regeneration.
The very first requirements of any implantable material
are related to the toxicological aspects: bone implants/
grafts need to be sterile, free of pyrogens, made of pure
molecules and biocompatible with tissues and body fluids
[1]. The classic paradigm of bone tissue engineering high-
lights several key players: a biocompatible scaffold, osteo-
genic cells, morphogenic signals and vascularization [2].
The biocompatibility requirement stresses the selection
of bone graft/implant composition so that it could be
accepted and integrated by the host tissue.
The biomaterial’s surface topography, chemistry and
mechanical characteristics influence cell functions by
triggering specific molecular events at the cell-material
interface: cell adhesion, spreading, migration, prolifera-
tion and differentiation [3-5].
One of the best biomaterials is titanium (Ti), which
stands out with its remarkable properties: good biocom-
patibility, low density, good mechanical properties and
better resistance to corrosion. But, even if well tolerated
by the human body, Ti and its alloys are bioinert and
cannot promote tissue bonding to the implant. Many
clinical problems regarding Ti implants are reported in
the literature, such as weakness of osseointegration in
the case of long-term implants and tissue inflammatory
response at the implantation sites due by release of titan-
ium particles in surrounding tissues [6-8]. Other problems
are caused by loss of ability of bone remodeling caused by
implant stiffness and biomechanical mismatch [9,10].
In order to solve those medical problems, surface coat-
ing of titanium implants with specifically engineered bio-
active materials is beneficial in that it stimulates new
bone formation and promotes better osseointegration
[11]. Bioactivity is a surface property of the implant which
allows the chemical integration of synthetic materials with
the host’s tissue, inducing the formation of extracellular
matrix with biomineralization of calcium phosphate nano-
crystallites at the bioactive substrate/tissue interface [12].
New methods that combine the bioactivity of HA or bio-
active glass and the mechanical properties of Ti or Ti al-
loys have been intensively investigated in the past decades,
and implants coated with plasma-sprayed HA have
already entered the clinical practice [13,14]. The chemical
and crystallographic structure of HA is similar to bone
minerals and consequently is biocompatible and osseo-
conductive, yet its poor mechanical properties are obsta-
cles in the designing of bone implants [15]. The release oftoxic elements by the metal implants coated with bioactive
ceramics and the differences in thermal expansion be-
tween the ceramic substrate and metal are other disadvan-
tages [16]. In order to avoid brittleness and to increase
the bond strength between HA and Ti alloys, different
methods of HA coatings were tested: plasma spray,
pulse laser-deposition [17,18], combined laser and in-
duction plasma spraying [19], mechanical alloying [20],
sol–gel process [21], HA growth in simulated body fluid
[22] or electrophoretic deposition [23]. A method for
obtaining biocomposites from Ti powder, HA and bio-
active glass, with the aim of improving the mechanical
and biological properties of HA, was described by Ning
et al. [15].
Bioactive glasses coatings of metal implants are also
used to improve bone-binding ability by promoting pro-
tein adsorbtion and forming biologically active apatite
layers upon implantation [24,14]. Saino et al. reported
enhancement of human osteoblasts SAOS-2 calcium de-
position after culturing on Ti-6Al-4 V scaffolds coated
with bioglass [25].
In the present study, the in vitro biocompatibility was
determined using Ti6Al7Nb implants with 25% total
porosity, processed with Selective Laser Melting (SLM)
technology, infiltrated with hydroxyapatite and silicatita-
nate using a sol–gel method, in an attempt to improve the
bioactivity of the material. Human osteoblast behavior
was observed in terms of adhesion, cell growth and differ-
entiation. The ability of Ti implants to induce osseoinduc-
tion was studied by scanning electron microscopy (SEM)
and fluorescence microscopy with cytochemical stains for
cell adhesion. Osteoblast proliferation was assessed through
viability tests and assessment of total protein synthesis,
whilst the expression of molecules involved in osteoblast
differentiation (osteopontin, osteocalcin, alkaline phosphase
and collagen) was investigated through immunocytochem-
ical staining and quantitative assays. The mineralization
process, as an important component of implant integra-
tion in bone tissue, was evaluated through measurements
of the calcium deposits on the Ti implants. The experi-
ments were conducted under different environmental
conditions: standard medium with fetal calf serum
(FCS), serum-free medium, specific osteogenic differen-




The atomized Ti6Al7Nb powder (MCP HEK GmbH),
medical grade, as the control material, was processed with
a Selective Laser Melting machine Realizer II SLM 250
with a Nd: YAG (fibre laser). Test specimens of 10 mm ×
5 mm × 3 mm were manufactured with a laser power of
50 W, the laser spot size 150 μm, layer thickness 50 μm,
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cessive layers were deposited in the “z” direction. The
samples were built on a titanium plate whose temperature
was kept at approximately 473°K (200°C), in argon atmos-
phere. The manufactured specimens were cleaned ultra-
sonically in distilled water for 10 min. and dried at 353°K
(80°C) for 30 min [26].
In order to improve the bioactivity of the resulted ti-
tanium base specimens, their pores were infiltrated with
calcium phosphate precipitates and silicatitanate gel, re-
spectively. Two types of calcium phosphate precipitates
A (pH = 4.5) and B (pH = 10) were synthetized through
wet chemical precipitation from calcium nitrate tetrahydrate-
Ca (NO3)2•4H2O and diammonium hydrogen phosphate-
(NH4)2HPO4 (Sigma Aldrich). The silicatitanate gel was
obtained by the sol–gel method from titanium isopropox-
ide (TIP) with the formula Ti{OCH(CH3)2}4 and tetraethy-
lorthosilicate (TEOS) with the formula Si(OC2H5)4. The
preparation of TiO2/SiO2 gel included 2 steps. The first
step involved the hydrolysis of Ti{OCH(CH3)2}4 to form
the uniform sol. TIP was diluted with ethanol and a small
amount of nitric acid HNO3 to form a transparent colloid.
Then, distilled water with a small amount of nitric acid
and the rest of ethanol were mixed together and dropped
into the above colloid solution. The molar ratio of Ti
{OCH(CH3)2}4:C2H5OH:H2O:HCl was 1:15:10:0.89. The
colloid was then left to homogenize at room temperature
for one hour. In the second step, TEOS was hydrolysed
with a molar ratio of Si(OC2H5)4:C2H5OH:H2O:HCl =
1:7.6:25:0.28. The TiO2 solution was then added dropwise
to the above SiO2 sol to form the transparent TiO2/SiO2
sol mixture. The transparent mixture was left to homogenize
at room temperature for 30 min before carrying out the
infiltration into the pores of the titanium base specimens.
Concerning the infiltration of porous titanium implants,
the obtained disks were immersed in the hydroxyapatite
(HA) solution and silicatitanate gel, kept in vacuum
(100 mbar) for 15 min. Subsequently, the samples were
dried at 60°C , then at 110°C in an oven. All the specimens
were sintered for 1 h in air atmosphere, using a furnace, at
600°C for samples with HA and 400°C for those infiltrated
with silicatitanate gel [20]. The infiltrated samples were
sterilized by exposing them to dry heat, at 180°C for
2 hours.
Cell culture
Human osteoblasts were isolated from patella bone
pieces harvested during arthroplasty as described by
Tomuleasa et al. [27]. Briefly, the bone fragments were
first mechanically processed and then digested for
30 min with an enzymatic cocktail: 0.1% colagenase IV
(Gibco) + 0.25% trypsin EDTA-4 (Sigma). The resulted
bone explants were cultured in Dulbecco’s modified Eagle’s
medium (DMEM)/F-12HAM (Sigma) containing 20% fetalcalf serum (FCS), 2 mM L-Glutamine, 1% antibiotics, 1%
non-essential aminoacids (NEA) (all reagents from Sigma),
in 25-cm2 culture flasks (Nunc) in a humidified 7% CO2
atmosphere. The first cells appeared near the explants
after 14 days and the culture reached confluence after 6–8
weeks, when the explants were removed and cells were
trypsinized and replated. The isolated cells were character-
ized at the second passage by immunocytochemical stain-
ing, showing positivity for osteoblastic lineage markers
such as osteonectin (ON) and osteopontin (OP). The ob-
tained cells showed a spindle-like shape in the first pas-
sages and a polygonal shape with multiple dendritic
extensions in more advanced passages. The medium was
changed twice each week and the cells were used after
four to six passages.
In the differentiation experiments we used serum-free
simple osteogenic medium (OS) consisting on DMEM/
F-12HAM without phenol red, 2 mM L-Glutamine, 1%
antibiotics, 1% NEA, 10 nM dexamethasone, 50 μg/ml
ascorbic acid and 10 mM β-glycero-phosphate or com-
plex osteogenic medium (OC) consisting of the above
mentioned simple osteogenic medium but supplemented
with growth factors: 3 ng/ml transforming growth factor
β1 (TGFβ1) and 4 ng/ml bone morphogenetic protein 2
(BMP2). All the reagents were purchased from Sigma
Aldrich. In some experiments cells were grown in the
absence of fetal serum (FCS) in DMEM/F12 HAM
medium without phenol red (serum-free medium, SF)
after day 18, considering that the cell environment is an
important component of variability in experiments and
that the proteins present in fetal serum (FCS) may inter-
fere with certain tests (e.g. determination of collagen or
other proteins).
Scanning electron microscopy (SEM)
The scaffolds seeded with osteoblasts were fixed with 4%
paraformaldehyde in phosphate buffered saline (PBS)
after 1 hour and 28 days of cultivation on Ti implants. Im-
plants were washed three times with PBS and immersed
in PBS before analysis. Specimens were characterized with
a Quanta 3D FEG Scanning Electron Microscope equipped
with an energy-dispersive X-ray microanalyzer (EDX).
Control implants without cells were also used for SEM
and EDX analysis.
Cell adhesion and proliferation
Cell adhesion at 2 hours and cell proliferation were
assessed with the Alamar blue test, which is used mainly
to measure cell viability. Resazurine, a non-fluorescent
dye is converted to resorufin (red fluorescence) in meta-
bolically active cells, through a reduction mechanism.
Fluorescence intensity depends on the number of viable
cells. 8 × 105 cells/well were suspended in 1.5 ml DMEM/
F12HAM complete medium and seeded on the implants
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triplicate. After 2 hours of cultivation, 150 μl of Alamar
blue (Invitrogen) were added to each well. The plates were
incubated for 1 hour at 37°C, in the dark. The medium
was subsequently transferred to another 12-well plate and
fluorescence intensity was measured using a BioTek
Synergy 2 plate reader (excitation 540 nm, emission
620 nm). The cells were quantified at different time inter-
vals: 2 hours, 24 hours, 9 days and 18 days.
Cell adhesion was also assessed through fluorescence
microscopy with cytochemical stains: DAPI (4,6-diamidino-
2-phenylindole) for nuclei and TRITC (tetramethylrhoda-
mine isothiocyanate) phalloidin (Sigma) for actin filaments.
After 1 hour cultivation in complete medium on the Ti
implants, cells were fixed with 4% paraformaldehyde solu-
tion and permeabilized with 0.1% Triton X-100 in PBS for
20 min at room temperature. TRITC phalloidine (1:20 in
PBS) was used for the staining of filamentous actin. The
samples were counterstained with an antifade medium
containing DAPI (UltraCruz™ Mounting medium-Santa
Cruz Biotechnologies) in order to highlight the nuclei.
Slides were examined in reversed phase fluorescence with
a Zeiss Axiovert D1 microscope, using filters at 340/
360 nm for DAPI and 546 nm for TRITC. Cultures of
osteoblasts on plastic dishes were used as negative con-
trols. Manufactured discs of synthetic resins composed
by 70% wt Bis-GMA(2,2-bis[4-(2-hydroxy-3-methacrylox-
ypropoxy)phenyl]-propane), 30% wt TEGDMA (triethy-
lene glycol dimethylacrylate), 1%DHEPT(Dihydroxyethyl-
P-Toluidine), 0.035%BHT (Butyl hydroxytoluene), 1.08%
BPO (Benzoyl peroxide) and 25.93% βTCP (Tricalcium
phosphate) were used as positive control in adhesion
studies.
Protein synthesis, as an indicator of cell proliferation,
was evaluated by determining the total protein content
in culture medium and cell lysates, using the microplate
BioRad Protein assay - a colorimetric assay based on the
Bradford dye-binding method. The test consists in obtain-
ing a calibration curve of standard proteins (bovine serum
albumine, BSA), which will serve for extrapolation of the
values obtained from samples in spectroscopy absorbance.
The osteoblasts were cultured on titanium implants, in
24-well plates, either in complete medium (with FCS) or
in serum-free medium. Ten microliters of medium were
collected from the cultures at different time points. Cell
lysis was performed with CelLyticTM MTMammalian
Tissue Lysis/Extraction ReagentCell (Sigma). Ten microli-
ters of samples as well as decreasing known concentra-
tions of standard BSA were added in each well of a 96-
well microplate. After adding 200 μl Dye Reagent (diluted
1:4 with deionizated water), the microplate was incubated
15 min at room temperature, and absorbance was mea-
sured with a BioTek Synergy 2 microplate reader at
595 nm.Cell differentiation and secretion of the extracellular
matrix
Osteopontin (OP) was evaluated in cell culture medium
(complete medium and serum-free medium) and cell ly-
sates, using a R&D Quantikine ELISA kit according to the
manufacturer’s instructions. Briefly, complete medium
was harvested at days 8, 14, 21 and 28 and serum-free
medium at day 21 and 28. Cell lysates were harvested after
8, 14 and 24 days of cultivation. In each well of a micro-
plate (coated with mouse monoclonal antibody against
OP), 50 μl of standards and undiluted samples were
added. After 2 hours of incubation at room temperature
and washing, 200 μl of OP conjugate were added, followed
by 2 hours incubation and further washing. After 30 min
incubation with the substrate solution, the stop solution
was added and optical density was determined with a mi-
croplate Biotek Synergy2 reader set to 450 nm.
Alkaline phosphatase (ALP) activity was assessed in
cell medium and cell lysates, using a fluorimetric Alkaline
Phosphatase detection kit (Sigma Aldrich). The culture
conditions were: medium with FCS, serum-free medium,
simple medium and complex differentiation medium.
Samples were harvested at different intervals, from 8 to
35 days. 20 μl from each sample, negative control
(DMEM/F12 HAM medium without phenol red) and
positive control were added in each well of a black 96-well
microplate. The samples were incubated for 20 min at 65°
C, cooled for 2 min on ice to stabilize at room
temperature and 180 μl mixture of Dilution Buffer and
Fluorescent Assay Buffer at 1:8 ratio were added. Activity
of alkaline phosphatase was measured at different points
in time, with a Biotek Synergy 2 fluorometer at 360 nm
excitation and 440 nm emission.
Calcium deposits that are formed after the mineralization
process can be highlighted with Alizarin red - an anthra-
quinone derivate and calcium chelator. Osteoblasts seeded
and cultivated on titanium implants, either in medium
with FCS or serum-free medium, were fixed with 4% para-
formaldehyde after 14, 21 and 28 days. After washing with
deionized water, Ti implants were incubated for 10 min
at room temperature with 2% Alizarin red solution
(pH 4.1). After intensive washing of implants a destain-
ing method was used, with 10% (w/v) cetylpyridinium
chloride (CPC) (Sigma) in 10 mM sodium phosphate
(pH 7.0). After 15 min at room temperature, aliquots
from the extracted stain were transferred to a 96-well
plate and diluted 10 fold with CPC solution. The violet-
colored supernatant was read with a microplate reader
at 562 nm.
Collagen detection
The most abundant protein of the extracellular matrix,
collagen, was determined with the SIRCOL collagen assay,
a colorimetric method based on staining of collagen with
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simple medium and complex osteogenic differentiation
medium. Medium was harvested at day 21 and 28 for
serum-free medium and at day 35 for differentiation
medium. 100 μl of collagen standards, samples, negative
controls (medium) and 1 ml Sircol Dye Reagent were
added to low protein binding microcentrifuge tubes and
incubated 30 min on an orbital shaker. After centrifuging
and draining the tubes, 750 μl of ice-cold Acid-Salt Wash
Reagent were added followed by another centrifugation
for removal of the unbound dye. 250 μl of Alkali Reagent
were used to release the Sircol dye from the collagen-dye
complex. Samples were transferred on a 96-well plate and
absorbance was measured with a microplate reader at
555 nm.
Immunocytochemical staining
Osteoblasts cultivated on titanium implants for 3, 14, 21
and 28 days in complete medium with FCS, were fixed
with 4% paraformaldehyde solution and permeabilized
with 0.1% Triton X-100 for 20 min at room temperature.
The samples were kept for 20 minutes at room temperature
with 10% BSA to avoid non-specific antibody binding.
Osteopontin, osteocalcine, and collagen 1A1 (all mouse
anti-human primary antibodies from Santa Cruz Biotech-
nologies) were diluted at a ratio of 1:50 in 1% BSA and in-
cubated overnight at 4°C with the samples. Secondary
goat anti-mouse antibodies IgG1 marked with FITC
(fluorescein isothiocyanate) and Texas Red (Santa Cruz
Biotechnologies) were added and incubated for 45–60 mi-
nutes at 37°C. Samples were counterstained with an anti-
fade medium containing DAPI in order to highlight the
nuclei and were subsequently examined with a reversed
phase epifluorescence Zeiss Axiovert D1 microscope at
488 nm for FITC, 546 nm for Texas red and 340/360 nm
for DAPI.
Statistical analysis
Statistical analysis was performed with the GraphPad
Prism 5 software, using the Bonferroni Multiple Com-
parison test. Statistical significance was set at p < 0.05.
Results
The success of bone grafting with Ti implants depends
on the properties of the implant (mechanical features,
surface structure, chemical and physical features, poros-
ity) and on the host’s characteristics (bone bed, associ-
ated diseases, etc.) [28]. The biochemical and biophysical
signals induced at the cell-material interface, which relay
complex information resulting from molecular, topo-
graphic and mechanical properties of the substrate, trig-
ger a cross-talk between the material and the cells with
consequences on cellfunctions such as: early attachment
(in the first seconds), cell adhesion and spreading,proliferation and differentiation [21]. The ability of the
biomaterial to promote cell adhesion and proliferation is
a critical factor for osseointegration. Adhesion allows the
host’s osteoblastics to attach to the substrate and activates
a complex machinery of reorganization of intra and extra-
cellular molecules. It promotes a specific cellular response
consisting of the induction of a differentiation processes
towards more specialized cell types, migration, proliferation
and gene expression of specific proteins [29]. To enhance
bone ingrowth, solutions to enhance surface modification
are currently being studied. One of the most promising is
bioactive coating which seems to accelerate new bone for-
mation at the bone–implant interface [30].
In the present study we used an original method to coat
the porous titanium implants, through infiltration with
calcium phosphate precipitates and silicatitanate gel, in
vacuum conditions followed by sintering at 600°C (for
samples with HA) and at 400°C (for silicatitanate sam-
ples). The total porosity of Ti control implants before
infiltration was evaluated by the Archimedes method
(ISO 2738–99) and reached values of nearly 25%. After
infiltration of implants total porosity decreased to 22%
for titanium infiltrated with hydroxiapatite and to 23%
for titanium infiltrated with silicatitanate. The micro-
structure was analyzed with a metallographic micro-
scope that revealed mainly irregular interconnected
pores, with a minimum diameter dmin = 70–100 μm and
a maximum diameter dmax = 200–400 μm [26]. Three
different porous titanium implants were obtained and
studied: porous titanium without infiltration (Ti Ctrl),
titanium infiltrated with hydroxiapatite (Ti HA) and ti-
tanium infiltrated with silicatitanate (Ti SiO2).
Structural analysis
The surfaces of the resulted implants were characterized
using scanning electon microscopy (SEM) and elemental
analysis by energy dispersive X-ray spectroscopy (EDX).
The SEM analysis revealed differences in the surface
structure for the three implants studied (Figure 1). Infil-
tration with HA yielded a rough surface consisting of
HA crystals covering almost entirely the titanium surface
(Figure 1B). In case of the silicatitanate-infiltrated titan-
ium (Ti SiO2), the pores were covered with silicatitanate
gel and the film coating was transparent and almost con-
tinuous (Figure 1C).
The EDX analysis showed a pronounced decrease in
titanium elemental content on the surface of HA infil-
trated samples (30.25%), and a much lower decrease in
Ti SiO2 implants (43.65%). The Ti implants infiltrated
with HA had a Calcium (Ca) content of 17.04% and a
Phosphorus (P) content of 7.37%, with a Ca/P ratio of
2.31 (Table 1).
Most studies in the literature reported Ca/P ratios ran-
ging between 0.5 and 1.9 [31]. Kitsugi et al. [32] used
Figure 1 SEM images of the surfaces of the studied substrate. Legend A. Non-infiltrated titanium, Ti Ctrl; B. Titanium infiltrated with
hydroxyapatite, Ti HA; C. Titanium infiltrated with silicatitanate, Ti SiO2 (magnification 240×).
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of 1.0, 1.5, 1.66 and 2. Transmission electron microscopy
analysis showed that the bone-bonding behavior of cal-
cium phosphate ceramics did not vary with the calcium/
phosphate molar ratio [32]. Silica content was 6.99%.
Osseoinduction: cell adhesion and proliferation
The adherence of cells to the materials was evaluated
through SEM imaging and cytochemical staining of nuclei
at 1 hour after seeding the cells on titanium implants.
Cell proliferation on substrates was assessed by a viabil-
ity assay (Alamar blue test) and by quantification of the
total protein contents in the cell culture medium or cel-
lular lysates.
SEM images were captured one hour after seeding the
implants with osteoblasts (Figure 2). We noticed changes
of cell shape, with development of dendritic extensions
and their attachment at several points, for the Ti Ctrl
(Figure 2A) and Ti SiO2 implants (Figure 2C). Cells
grown on Ti HA implants maintained a rounded shape
(Figure 2B). Our observations are in agreement with
certain data from the literature. A similar behavior of
the biomimetic apatite that restricted spreading and
promoted extension of cellular projections of MC3T3-










Aluminum 9.65 1.42 4.46
Niobium 3.37 0.78 1.43




Legend: HA- hydroxyapatite, SiO2- silicatitanate.observed through confocal microscopy by Chou et al.
[33]. In a comparative study of the attachment of osteo-
blastic cells on titanium and hydroxyapatite, Goto et al.
[34] found more osteoblasts attached on HA surface
which did not form well-defined and polarized stress fi-
bers or vinculin-positive focal adhesions (as did those
cultivated on Ti surface).
A quantitative morphometric analysis of cell adhesion
was also performed on cells stained with DAPI (for nuclei)
and TRITC phalloidin (for actin F). The images were cap-
tured with a CCD camera (Axiocam MRM) adapted to a
Zeiss Axio Observer D1 inverted microscope and analysed
using Axiovision Release 4.6.3. software. The software was
calibrated to measure actual dimensions for the 10× ob-
jective lens using a stage micrometer. Adherent cells were
observed on the surface of plastic dishes (negative control)
and on all titanium implants in a similar number. Positive
control consisting by resins compound discs did not allow
cells attachment (Figure 3).
Cells were counted in 3 different microscopic fields,
through random selection. Using the unpaired t test with
Welch’s correction we found statistically significant
differences between the Ti Ctrl and the other implants
(Ti HA, Ti SiO2 and positive control) with the first
more intensely promoting cell attachment in the first
hour (Figure 4).
Osteoblast adhesion at two hours and their prolifera-
tion at 24 hours, 9 days and 18 days were evaluated
using the Alamar blue assay. The results are illustrated
in Figure 5 and they show a similar ability of all implants
to induce cell adhesion early after seeding.
The differences between the Alamar blue test results
and cell count results can be explained by the fact that
Alamar blue test incorporates a fluorometric/colorimetric
REDOX indicator based on detection of innate cellular
metabolic activity. Another possible explanation is that
the cells were counted at 1 hour after seeding and the via-
bility test was performed at 2 hours, and this period of
Figure 2 SEM images of the of studied substrates 1 hour after seeding with osteoblasts, showing cells attached to the surface of the
implants. Legend: A. non-infiltrated titanium, Ctrl Ti (magnification 8000×); B. titanium infiltrated with hydroxyapatite, Ti HA (magnification
8000×); C. titanium infiltrated with silicatitanate, Ti SiO2 (magnification 6000×).
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hesion on Ti HA implants. In some experimental models
it was shown that certain reductases involved in the re-
duction of Alamar blue are present not only in mitochon-
dria, but in subcellular components and Alamar blue
reduction may signify an impairment of cellular metab-
olism [35]. Some interactions and assay compatibility
problems have been specifically demonstrated in screen-
ing bioengineered nanomaterials [36]. Another possible
explanation is the integrin-triggered production of re-
active oxygen species (ROS) derived from mitochondria
by signals generated during the early phase of cell attach-
ment with associated changes in the cytoskeleton and in
the phosphorylation levels of several proteins [37].
In our experiments, the statistical analysis with Two-
way ANOVA Bonferroni posttests showed a significant in-
crease of sample fluorescence intensity for all Ti implantsFigure 3 Fluorescence images (magnification 100×) of osteoblasts att
cultivated on plastic dihes-negative Ctrl, non-infiltrated titanium Ti Ctrl, t
with silicatitanate Ti SiO2, composite resins as positive Ctrl. Staining was
(for actin F, red staining).and controls cells without substrate after 9 days of cultiva-
tion, with a significant advantage for Ti SiO2 implants.
Cell viability decreased dramatically after 18 days, as a
possible consequence of the progression of the cells to a
more advanced stage of differentiation.
The effect of various substrates and media formulation
on cell growth and proliferation was determined by the
assessment of the rate of total protein synthesis using
the microplate BioRad Protein test. The results are dis-
played in Figure 6.
In the presence of fetal serum, no significant differences
between samples were observed (Figure 6A). Differences
emerged when cells were cultivated in serum-free conditions,
especially for cells grown on Ti SiO2 implants (Figure 6B).
Statistical analysis with two-way ANOVA Bonferroni posttest
showed significant differences at 28 days, favoring the im-
plants of Ti infiltrated with SiO2 (***p < 0.001).ached to the surface of the studied implants. Legend: cells
itanium infiltrated with hydroxyapatite Ti HA and titanium infiltrated
made with DAPI (for nuclei, blue staining) and TRITC-phalloidin
Figure 4 Cell count results one hour after seeding of the
osteoblasts on the implants. Legend: cells cultivated on plastic
dishes-Negative Ctrl, noninfiltrated, control Ti (Ti control), titanium
infiltrated with hydroxyapatite (Ti HA), Ti infiltrated with silicatitanate
(Ti SiO2) and composite resins as positive Ctrl.
Brie et al. Journal of Biological Engineering 2014, 8:14 Page 8 of 19
http://www.jbioleng.org/content/8/1/14It is known that cellular lysates should reflect the amount
of total intracellular proteins. Protein levels were deter-
mined in the cellular lysates using the same microplate
BioRad Protein assay. We found that the protein levels in
the cellular lysates decreased progressively in time in all
Ti samples (Figure 7).Figure 5 The viability of the osteoblasts on the titanium
implants, evaluated with Alamar blue assay and showing their
adhesion to the substrates (at 2 h) and their proliferative
capacity (on day 1, 9 and 18 day). Legend: noninfiltrated, control
Ti (Ti control), titanium infiltrated with hydroxyapatite (Ti HA), Ti
infiltrated with silicatitanate (Ti SiO2), cells cultivated on plastic
dishes (ctrl ) ***p < 0.0001.This finding suggests a decreased synthesis of proteins
when cells progress in more advanced stage of differenti-
ation, a decrease in cell number (as observed with Alamar
test), or both.
Osseoconductivity and osseointegration: osteoblast
differentiation and de novo mineralization
In the present study, OP was determined through an
ELISA method both in cell culture medium (complete
and serum-free mediums) and in cellular lysate. The
evaluations were made in samples harvested at day 8, 14,
21 and 28 in the case of medium with FCS and at day 21
and 28 for serum-free medium. Cell lysates were har-
vested after 8, 14 and 24 days of cultivation (Figure 8).
Medium collected from osteoblasts cultured on plastic
dishes was used as for comparison.
One interesting finding is that of consistently higher
values of the OP in samples grown on plastic in the
presence of FCS (Figure 8A). One explanation might in-
volve the immobilization of the OP protein in the newly
synthesized matrix on Ti implants. We also found differ-
ences in OP secretion depending on culture conditions:
in simple osteogenic medium, OS (containing 10 nM
dexamethasone, 50 μg/ml ascorbic acid and 10 mM β-
glycero-phosphate) or in complex osteogenic medium,
OC (supplemented with growth factors: 3 ng/ml TGFβ1
and 4 ng/ml BMP2) (all reagents acquired from Sigma
Aldrich). These differentiation-favorable environments
induced an increase in the OP level for the Ti Ctrl im-
plants (Figure 8B).
The assessment of OP levels in cell lysates, at 8 and
14 days of culture, showed no differences between sub-
strates (Figure 9).
The expression of OP was also studied in immuno-
stained samples fixed after 3, 14 and 21 days. Each types
of implant (Ti Ctrl, Ti HA and Ti SiO2) showed positivity
for OP until day 14, after which the protein expression de-
creased (Figure 10). This phenomenon can be explained
by an earlier initiation of the mineralization process (espe-
cially for implants with HA), which could be correlated
with the disappearance of OP, as some authors consider
OP as an inhibitor of mineralization [38,39].
For a better visualization of the expression of OP and
of cell adhesion to the implants’ surface, we used a triple
staining with fluorescein isothiocyanate (FITC) for osteo-
pontin expression, phalliodin TRITC for F-actin fibers and
DAPI for nuclei (Figure 11).
This triple coloration allowed a more accurate observa-
tion of osteoblasts cultured for 14 days on titanium im-
plants. DAPI staining of nuclei showed the number per
microscopic field of cells adhered to the implants’ surface,
with no notable differences between implants. OP protein
stained with FITC-conjugated antibodies, showed charac-
teristic intracellular aggregates with increased fluorescence
Figure 6 Levels of total proteins secreted in culture mediums by osteoblasts cultivated on the implants’ surface, measured with the
Bio-Rad protein microplate assay. A. in complete medium with fetal calf serum, FCS (measured on day 8, 14, 21 and 28); B. in serum-free
medium (measured on day 21 and 28) Legend: noninfiltrated, control Ti (Ti control), titanium infiltrated with hydroxyapatite (Ti HA), Ti infiltrated
with silicatitanate (Ti SiO2), cells cultivated on plastic dishes (ctrl).
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http://www.jbioleng.org/content/8/1/14intensity in cells cultivated on Ti Ctrl and Ti SiO2 im-
plants. Cells grown on the HA implants were probably
embedded and masked by HA crystals. Actin filaments
(stained with TRITC phalloidin) had a more intensive and
obvious expression in the case of control Ti and SiO2 Ti
implants, as these substrates promoted the adherence of
osteoblasts on a larger area while also inducing a flattened
shape and the development of dendritic spines. Cells
grown on Ti HA had a more compressed cell body with
extensions that could not be seen due to the HA layer. In
our experiments only Ti SiO2 implants showed expression
of stress fibers.
Osseointegration is a later stage in the evolution of
an implant and is characterized by the establishment ofFigure 7 Levels of total proteins secreted in cellular lysates of
osteoblasts cultivated on the implants and collected on day 8,
14 and 24, as measured with the Bio-Rad protein microplate
assay (***p < 0.001; **p < 0.01). Legend: noninfiltrated, control Ti
(Ti control), titanium infiltrated with hydroxyapatite (Ti HA), Ti
infiltrated with silicatitanate (Ti SiO2), cells cultivated on plastic
dishes (ctrl).bone-implant contact and the development of peri-implant
bone as a consequence of osteogenic mineralization [40].
In the present study, mineralization was assessed by quan-
tifying calcium deposition on Ti implants with a modified
Alizarin red method. Evaluations were made in Ti im-
plants seeded with osteoblasts, after 14, 21 and 28 days of
cultivation in medium with FCS or serum-free medium.
Because Ti HA implants contain large amounts of cal-
cium, we assessed the amount of calcium in Ti HA im-
plants without cells growing on their surface and the
results were subtracted from those obtained for Ti HA
implants cultivated with cells.
In the first 14 days an equal amount of calcium was
observed in all titanium implants, when cultivated in
complete medium. After 21 and 28 days of cultivation in
complete medium, a gradual increase in calcium deposits
occurred mostly in Ti HA implants and, in a lower degree,
in Ti SiO2 implants. Serum-free medium significantly in-
creased the deposition of calcium on the surface of Ti HA
implants and on control samples after 28 days of cultiva-
tion (Figure 12).
Evaluation of alkaline phosphatase (ALP) activity in
the environment of osteoblasts cultured on Ti implants
revealed different cell behaviors depending on the type
of cultivation medium (medium with FCS, serum-free
medium, simple osteogenic and complex osteogenic dif-
ferentiation medium), culture duration and the type of
titanium implants (Figure 13). The highest levels of ALP
activity were obtained in Ti Ctrl implants and controls
without substrate after 14 days of cultivation in
complete medium and for Ti SiO2 implants after 21 days
(Figure 13A). (Two-way ANOVA Bonferroni posttest;
**p < 0.01). A common trend of progressive decline in
ALP activity was observed after 28 days. In serum-free
Figure 8 Levels of osteopontin (OP) secreted in the culture medium by osteoblasts cultured on the implants’ surface. A. in medium wih
fetal calf serum (FCS), collected on day 8, 14, 21 and 28 (analysis with two-way ANOVA Bonferroni posttest *p < 0.05; **p < 0.01; ***p < 0.001); B. in
serum-free medium (collected on day 21 and 28), in simple (OS) and in complex (OC) differentiation mediums (collected on day 35). Legend: cells
cultivated in plastic dishes (ctrl), non-infiltrated, control Ti (Ti control), titanium infiltrated with hydroxyapatite (Ti HA), Ti infiltrated with
silicatitanate (Ti SiO2).
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http://www.jbioleng.org/content/8/1/14conditions ALP activity increased significantly after
21 days in Ti SiO2 implants, and after 35 days in Ti Ctrl
and Ti HA implants as well control samples in simple
osteogenic medium (Figure 13B). (Two-way ANOVA
Bonferroni posttest; *p < 0.05; **p < 0.01).
ALP activity was also evaluated in cellular lysates ob-
tained after 8 and 14 days of osteoblast cultivation. The
results showed higher levels of the enzyme in cellular ly-
sates when compared with the complete medium-derived
samples. At 14 days, the highest ALP activity was found in
the lysates obtained from the cells cultivated on Ti SiO2
implants (Figure 14).Figure 9 Levels of osteopontin (OP) in cellular lysates of
osteoblasts cultured on the titanium implants and measured
on day 8 and 14 of cultivation. Legend: non-infiltrated, control
Ti (Ti control), titanium infiltrated with hydroxyapatite (Ti HA), Ti
infiltrated with silicatitanate (Ti SiO2), cells cultivated on plastic
dishes (ctrl).Collagen detection
Levels of the most abundant protein of the extracellular
matrix, collagen, were determined with the SIRCOL colla-
gen assay, in samples cultured in serum-free medium (SF),
simple osteogenic medium (OS) and complex osteogenic
differentiation medium (OC). Medium was harvested on
day 21 and 28 (for the serum-free medium) and on day 35
(for the two differentiation mediums). In the serum free
medium, an important increase in soluble collagen con-
centration was seen on day 28 (compared with day 21) for
the Ti SiO2 implants (Figure 15). The results also showed
significant differences between culture mediums with re-
spect to their content in soluble collagen, as one-way
ANOVA tests showed. Notable differences were observed
between all samples of Ti implants and control without
substrate cultivated in medium with FCS and samples cul-
tivated 28 and 35 days in simple osteogenic medium (OS)
and complex osteogenic medium (OC). Analysis with
two-way ANOVA Bonferroni posttest; *p < 0.05 showed a
significant increase of soluble collagen in control samples
after 35 days of cultivation in OC medium (Figure 15).
Collagen secretion was also investigated by immuno-
cytochemical staining of cells grown on titanium sam-
ples. Type I collagen was expressed by all samples grown
on titanium, with a higher observed intensity in control
Ti and Ti infiltrated with SiO2 after 14 days and much
more intensely after 28 days of cultivation (Figure 16).
The osteoblast-osteocyte transition was observed after
28 days of cultivation especially on titanium samples with
SiO2 and in a lower degree on control titanium-cultured
samples. This was suggested by the strong expression of
osteocalcin, as revealed through immunocytochemical
staining. In silicatitanate- and HA-infiltrated implants,
Figure 10 Immunocytochemical staining of the osteoblasts cultivated on the surface of the implants showing the expression of
osteopontin (OP). Osteoblasts were stained with an anti OP-FITC monoclonal antibody on day 3, 14 and 21 days (magnification 100×). Legend:
non-infiltrated control Ti (Ti control), titanium infiltrated with hydroxyapatite (Ti HA), Ti infiltrated with silicatitanate (Ti SiO2).
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http://www.jbioleng.org/content/8/1/14deposition of osteocalcin seems to occur in the extra-
cellular matrix, with a more uniform distribution of the
protein observed in the case of SiO2 implants. In com-
parison, in control titanium implants osteocalcin was
located in the intracellular space of the osteoblasts
(Figure 17).
SEM images taken after 28 days show various obvious
morphological changes of cells depending on the type of
implant. A typical osteocytic morphology - with long
dendrite-like processes interacting with neighboring cells -
was observed mainly on the SiO2 surface implant and to a
lesser extent in control titanium (Figure 18A and C). TiFigure 11 Immunocytochemical staining of osteoblasts on the surfac
infiltrated with SiO2) showing the expression of actin F and osteopon
antibody, phalloidin TRITC (for actin F) and DAPI (for nuclei). The images w
image analysis software (magnification 200×). Legend: non-infiltrated, cont
infiltrated with silicatitanate (Ti SiO2).HA implants had a more particular morphology: the cells
appeared to be partially included in the HA and in the
newly formed matrix substrate. The cell extensions were
also likely to be masked (Figure 18B).
Discussions
Osseoinduction, osteoconduction and osseointegration
are the three interdependent steps involved in bone
healing, and the specific response of the bone to implant
insertion is similar to its response to fractures [41].
Osseoinduction – defined by Friedenstein in 1968 as the
recruitment of undifferentiated osteoprogenitor cells ande of the implants (noninfiltrated Ti, Ti infiltrated with HA and Ti
tin (OP). Osteoblasts were stained with anti OP-FITC monoclonal
ere taken on day 14 and composed with Axiovision Release 4.6.3.
rol Ti (Ti control), titanium infiltrated with hydroxyapatite (Ti HA), Ti
Figure 12 Levels of calcium deposition on the implants by
osteoblasts cultured in medium with fetal calf serum, FCS
(measured on day 14, 21 and 28) and in serum-free medium,
SF (measured on day 21 and 28). Quantification of the Calcium
content was done using a modified Alizarin red method. Legend:
noninfiltrated, control Ti (Ti control), titanium infiltrated with
hydroxyapatite (Ti HA), Ti infiltrated with silicatitanate (Ti SiO2), cells
cultivated on plastic dishes (ctrl).
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http://www.jbioleng.org/content/8/1/14their induction into osteogenic competent cells - depends
mainly on cell adhesion phenomena [42,36]. The quality
of the interface between cells and implants is essential for
the induction of events involved in implant integration
[43]. The adhesiveness of bone grafts/implants is related
to their ability to support selective attachment, prolifera-
tion, differentiation and migration of anchorage-dependent
cells [44]. Some examples of osseoinductive materials used
as implants are: the polymer polyhydroxyethylmethacrylate
(poly-HEMA), metals (porous titanium), natural mate-
rials such as hydroxyapatite (HA), synthetic ceramicsFigure 13 Levels of alkaline phosphatase activity in the mediums con
wih fetal calf serum (FCS), evaluated on day 8, 14, 21 and 28 (*p < 0.05); B.
and complex (OC) differentiation mediums (collected on day 35) Legend: n
hydroxyapatite (Ti HA), Ti infiltrated with silicatitanate (Ti SiO2), cells cultivatand composites such as HA/poly(lactic-coglycolic acid)
(PLGA) or HA/collagen [2].
The aim of this study was to compare the osseoinduc-
tive, osteoconductive and osseointegrative properties of
two kinds of titanium implant coatings, with the purpose
of selecting materials with increased bioactivity. Ti6Al7Nb
implants with 25% total porosity, processed with SLM
technology, were infiltrated with hydroxyapatite and silica-
titanate through a sol–gel method. Gravimetric method
revealed a slow decrease of porosity to 22% for Ti HA im-
plants and to 23% for Ti SiO2. Uncoated Ti implants were
used as controls. SEM and EDX analysis revealed that the
two methods of coating conferred, as expected, different
physical and chemical properties. For the Ti Ha implants,
the EDAX analysis resulted in 30.25% Ti content (A%)
with a Ca/P ratio of 2.3. The attachment of cells on the Ti
HA scaffolds was delayed in the first hour when compared
to Ti SiO2 and porous uncoated Ti implants, as revealed
by SEM images and cell counting. However, this initial
disadvantage was subsequently surmounted, as evidenced
by the assessment of proliferation with Alamar blue and
total protein content. The metabolic activity of osteoblasts
was highest after 8–9 days of cultivation in all Ti implants,
with an observed advantage in SiO2 infiltrated Ti im-
plants. This advantage was maintained until day 28, as
proved by the increasing protein content in serum-free
medium. Similar results were obtained by Waselau et al.
[45] in a comparative study analyzing the effects of bio-
active glass S53P4 and beta-tricalcium phosphate on
osteogenic differentiation of human adipose stem cells in
the presence of BMP-2 and BMP-7. qDNA measurements
revealed significantly greater cell populations in the casetaining osteoblasts cultured on implant surfaces. A. in medium
in serum-free medium, SF (collected on day 21 and 28), simple (OS)
oninfiltrated, control Ti (Ti control), titanium infiltrated with
ed on plastic dishes (ctrl).
Figure 14 Levels of alkaline phosphatase activity in cellular
lysates from osteoblasts cultured on titanium implants in
complete medium with fetal calf seum, FCS. Evaluation on day 8
and 14. Legend: noninfiltrated, control Ti (Ti control), titanium
infiltrated with hydroxyapatite (Ti HA), Ti infiltrated with silicatitanate
(Ti SiO2), cells cultivated on plastic dihes (ctrl).
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http://www.jbioleng.org/content/8/1/14of bioactive glass used with control medium after 7 days
and in osteogenic medium after 14 days [45].
The HA coatings are biomimetic and many studies
proved their osteoconductivity. On the other hand, their
osseoinductive ability is more controversial and still highly
debated. This may be due to differences in the manufac-
turing process, which result – even in case of equal
chemical compositions – in different levels of micropor-
osity and surface roughness, which are essential factors
that determine the osseoinductive potential of the ma-
terial [42,36].
The silicatitanate gel used for Ti coating in our exper-
iments contained 6.99% silica and demonstrated a good
osteoinductive activity, sustaining cell adhesion andFigure 15 Levels of soluble collagen produced by the osteoblasts cul
day 21 and 28), simple (OS) and complex (OC) differentiation medium
titanium infiltrated with hydroxyapatite (Ti HA), Ti infiltrated with silicatitana
ANOVA analysis reveals statistical differences between the medium of cultiproliferation. The sol–gel method used for obtaining
this coating is now preferred to the classical melting
method because of its advantages [46]. It is a much
more flexible method for obtaining amorphous multi-
component oxide systems of high purity and homogen-
eity, at lower temperatures, with a controlled porosity
[47]. By forming nanopores in the glass, the surface area
becomes enlarged and provides sites for cell attachment
[48,49]. Also, the hydroxyl groups located in the sol–gel
of bioactive glasses structures confer a higher bioactivity
when compared to the bioactive glasses prepared by
melting techniques. In addition, by releasing soluble silica
and calcium ions, it promotes differentiation of osteopro-
genitor cells [50,51]. Many in vitro studies investigated the
role of silicon (Si) in bone homeostasis and reported that
Si increased the synthesis of non-collagenous matrix poly-
saccharides and of collagen, due to increased prolyl-
hydroxylase activity (the enzyme involved in collagen syn-
thesis). Si also exerts a direct influence on osteoblasts,
promoting cell proliferation, extracellular matrix synthesis,
alkaline phosphatase (ALP) activity and osteocalcin syn-
thesis [52].
Osteoconductive materials allow bone growth on the
surface of materials and into their pores, channels or
pipes, which also depends on previous osseoinduction
and on proper blood supply. Signals from cells adhered
to the biomaterial’s surface trigger the secretion of many
growth factors with mitogenic and angiogenic activity,
such as: insulin-like growth factors I and II (IGF I, II),
fibroblast growth factor (FGF), transforming growth fac-
tor (TGF-β), vascular endothelial growth factor (VEGF)
and platelet-derived growth factor (PDGF), as well as the
secretion of bone tissue-related growth factors with
osteogenic potential: bone morphogenic proteins 2 andtured on titanium implants in serum-free medium (collected on
s (collected on day 35). Legend: noninfiltrated, control Ti (Ti control),
te (Ti SiO2), cells cultivated on plastic dihes (ctrl) Table: One-way
vation (SF vs. OS and OC serum-free medium).
Figure 16 Immunocytochemical staining (FITC) for collagen 1A of the osteoblasts cultured in complete medium on titanium implants
and evaluated on day 14 and 28. Legend: noninfiltrated control Ti (Ti control), titanium infiltrated with hydroxyapatite (Ti HA), Ti infiltrated with
silicatitanate (Ti SiO2) (magnification 100×).
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http://www.jbioleng.org/content/8/1/147 (BMP-2 and BMP-7) [3,45]. Osseointegration allows
bone anchorage and consolidation between the newly
formed bone and the implant. Because initial osseointe-
gration is dependent on bone induction and conduction,
materials that are too toxic to allow cellular adhesion
and development into bone forming cells will not be
osseointegrated [3]. Formation of hydroxyapatite and
surrounding bone tissue by binding to the extracellular
matrix is essential for osseointegration. The most im-
portant questions to answer when investigating a system
of osteoblasts cultured on implants are whether the sub-
strate supports de novo matrix mineralization, if it is
similar to its naturally occurring counterpart, and how it
could be distinguished from the presence of minerals
contained in the substrate.
Osteoconductivity and osseointegration of Ti HA, Ti
SiO2 and porous Ti implants used in the present study
were evaluated by assessing the differentiation and
mineralization processes. Osteopontin (OP) is one of the
most important non-collagenous phosphoproteins and
an indicator of the differentiation process of osteoblasts.Figure 17 Immunocytochemical staining for osteocalcin Texas red, co
medium on titanium implants evaluated after 28 days of cultivation.
hydroxyapatite (Ti HA), Ti infiltrated with silicatitanate (Ti SiO2) (magnificatioOP expression was evaluated in different culture media
(complete medium, serum-free medium and osteogenic
medium) at different points in time. Using the ELISA
method, no significant differences were found among
the implants. Interestingly, the highest OP values were
detected on day 14, for the cultures grown in complete
medium on plastic dishes. This may be explained by the
immobilization of OP on the implant surface in the
newly synthesized matrix, as OP was reported to be
present both in an immobilized form in the extracellular
matrix of mineralized tissues and in a soluble form in
tissue fluids [53,54]. The osteogenic differentiation medium
induced a discrete increase in OP levels after 35 days of
osteoblast cultivation on control Ti implants. A strong OP
expression, evaluated by immunocytochemical staining,
was detected after day 3 for Ti Ctrl and Ti SiO2 implants.
It continued to increase until day 14 and decreased after
21 days. With a combined immunostaining for osteopon-
tin and filamentous actin, different behaviors of implants
were observed with regard to the rearrangement of actin
fibres. The Ti SiO2 and Ti Ctrl implants induced a moreunterstained with DAPI in osteoblasts cultured in complete
Legend: non-infiltrated, control Ti (Ti control), titanium infiltrated with
n 100×).
Figure 18 Scanning electron microscopy images of osteocytes attached to the surface of titanium implants after 28 days of
cultivation. Legend: Osteocytes are indicated by arrows. A. noninfiltrated control Ti (magnification ×300); B. Ti infiltrated with hydroxyapatite
(Ti HA) (magnification ×500); B1- image of an osteoblast with 2000× magnification; C. Ti infiltrated with silicatitanate (TiSiO2) (magnification ×1200);
C1- image of an osteocyte with ×2500 magnification.
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http://www.jbioleng.org/content/8/1/14flattened morphology of cells, and were associated with
the expression of stress fibers.
The actin cytoskeleton is involved in cell adhesion and
cell motility, and its fiber arrangement modulates cell
shape differently depending on the type of nanoscale
and microscale surface roughness as well as the pattern-
ing of the surface of the material on which cells are
grown. Mechanical stimulation of osteoblasts or stem
cells induced by the properties of the implant surface
triggers the reorganization of the focal adhesion plaques
followed by the rearrangement of the cytoskeleton and
the activation of signaling pathways involved in osteo-
genic cell differentiation such as transcription factors
Cbfa1 (Core Binding Factor A1) and Osterix. As a con-
sequence osteoblasts synthesize higher amounts of colla-
gen I, osteopontin, osteocalcin and bone sialoprotein,
and induce higher levels of alkaline phosphatase activity
[55-57]. The canonical Wnt (Wingless/Integrated) signal-
ing pathway is also activated with consequences on β-
catenin, alkaline phosphatase and osteocalcin expression,
as Galli et al. showed in a study using mesenchymal and
osteoblastic cells growing on polished titanium discs ver-
sus acid-etched and sand-blasted (SLA) surfaces. Differ-
ences were also observed among various cell types [58].
For instance, OP is also involved in cell adhesion phenom-
ena of cell-cell or cell-extracellular matrix interactions
that occur during cell proliferation and migration. Ele-
vated concentrations of osteopontin were found in sites of
bone resorption and its expression was strongly increased
by mechanical stimuli. The effects of OP on HA formation
seem to be related to its phosphorylation state. Exogenous
phosphorylated OP is known to inhibit mineralization, but
dephosphorylation by tissue-nonspecific alkaline phos-
phatase (ALP) reverses this effect [38,39]. The phospho-
rylation state of OP can be influenced by the physical
and chemical properties of the substrate and, as aconsequence, modulates its signaling ability [59]. This fact
may explain the different cell responses observed in our
experiments, most notably the increased expression of OP
in complete medium after 8–14 days especially in SiO2 Ti
and control Ti implants, which correlates with concomi-
tant increases of other specific proteins such as ALP.
ALP is a key enzyme that can both promote and inhibit
mineralization. It is a cell-membrane-associated enzyme,
expressed also in matrix vesicles, and in association with
other proteins enhances deposition of hydroxyapatite
along the collagen fibrils. ALP hydrolyzes its substrate, in-
organic pyrophosphate, to inorganic phosphate, the latter
being a substrate for the HA mineral [60]. In our experi-
ments, the highest activity of ALP was found in the sam-
ples obtained from the lysate of cells cultivated on Ti SiO2
implants. However, the activity of ALP was much higher
(2–2.5 fold) in serum-free conditions, especially in Ti HA
and SiO2 implants. ALP activity decreased rapidly after
28 days, indicating that the mineralization process is
nearly complete. In osteogenic differentiation mediums,
the expression profile of ALP was different. A strong ALP
activity was detected on day 35 in simple osteogenic
medium from the Ti Ctrl and Ti HA, accompanied by ele-
vated levels of collagen. SiO2 implants did not respond to
the differentiation medium in terms of ALP activity, but
exhibited similar levels of collagen. The presence of BMP-
2 and TGF β1 in the complex osteogenic medium in-
creased ALP activity only in Ti HA implant cultures
(Figure 19).
Collagen synthesis, as an indicator of matrix forma-
tion, was significantly increased in Ti SiO2 samples after
28 days. In addition, higher soluble collagen levels were
observed in control Ti and Ti SiO2 implants cultivated
in simple osteogenic differentiation medium. These find-
ings do not exclude possibly similar collagen synthesis
on Ti HA implants, yet we could not demonstrate this
Figure 19 A schematic synthesis of results regarding the most important elements implicated in the mineralization process. Ca2+
deposition, collagen synthesis and ALP activity, in samples cultivated in serum-free medium (SF) and in differentiation medium (complex osteogenic
medium OC and simple osteogenic medium OS) Legend: noninfiltrated, control Ti (Ti control), titanium infiltrated with hydroxyapatite (Ti HA), Ti
infiltrated with silicatitanate (Ti SiO2).
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http://www.jbioleng.org/content/8/1/14because in such implants the collagen fibers could not
be visualized (as they may have been masked by the ac-
celerated deposition of newly formed HA crystals).
Calcium deposition was investigated as a marker of
mineralization. Differences between implants emerged
after 21 and 28 days of cultivation in complete medium,
with a gradual increase in calcium deposition observed
mostly in Ti HA implants and in a lower degree in Ti
SiO2 implants. Serum-free medium significantly in-
creased the deposition of calcium on the surface of Ti
HA implants after 28 days of cultivation. A similar out-
come was reported by Yamada et al. [61], as they ob-
served accelerated bone-implant integration after the
addition of pure nanopolymorphic crystalline HA to
micro-roughened titanium, as well as a significantly in-
creased osteoconductivity [61].
The complex osteogenic differentiation medium used
in this study also contained TGF-β1 (in a low dose-3 ng/
ml), a growth factor with dual biological activity, as it
can regulate osteoblast differentiation not only positively
but also negatively. Ochiai et al. [62] observed that only
repeated high doses of TGF-β1 suppressed osteoblast
differentiation with decreased ALP activity, although a
unique low dose of TGF-β1 strongly induced osteoblast
differentiation [62]. On the other hand, TGF-β1 protects
pre-osteocytes from apoptosis [63]. Similar results regard-
ing the osteogenic medium were obtained by Tirkkonen
et al. [64] in an adipose stem cell osteogenic differentiation
study that compared the efficiency of BMP-2 and BMP-7,
VEGF and osteogenic medium. Stem cells were grown on
commercially available bioactive glass scaffolds and bi-
phasic granules. The bioactive glass induced an increased
cell proliferation whereas calcium phosphate led to a more
significant collagen production. They did not find a bene-
fit after the addition ofgrowth factors in comparison with
plain osteogenic medium. Moreover, BMP-7 inhibited the
proliferation and osteogenic differentiation of adipose
stem cells [64]. The lack of improvement of the osteogenicdifferentiation of stem cells through the addition of BMP-
2 or BMP-6 was also reported by other authors [65-67].
The master of controlling osteoblast differentiation into
osteocytes is RUNX2 (runt-related transcription factor)
[68] and in this context BMP2 induces osteoblast differ-
entiation through Runx2-dependent ATF6 (bZIP tran-
scription factor) expression, which directly regulates
osteocalcin transcription [69]. Prior to the mineralization
process, as the cells pass through progressive differenti-
ation stages, some specific markers are revealed, the earli-
est being RUNX2, followed by ALP (an early-mid marker),
osteopontin (OP), osteocalcin (OC) and osteonectin (ON)
[70]. Roach (1996) studied the roles of matrix non-
collagenous proteins such as OP, OC, bone sialo-protein
(BSP) and ON and their tissue localization using double
immuno-histochemistry. The appearance of OP and BSP
ahead of the mineralization front, prior to mineralization,
suggested that both proteins are necessary for the initi-
ation of bone mineralization. OC and ON were present in
fully mineralized matrix, possibly having a function in
controlling the amount and rate of crystals formation [71].
In our study, after the immunocytochemical analysis,
osteocalcin had the highest expression in Ti SiO2 and
Ctrl Ti implants after 28 days of cultivation, and it was
associated with increased expression of collagen I. Such
effects of bioactive glass were explained by Silver et al.
[72], through a marked alkalinization of the intracellular
and extracellular environment that influence the activ-
ities of intracellular enzymes and signaling pathways,
which in turn increases collagen synthesis [72]. Similar
observations were reported regarding orthosilicic acid or
different types of bioglasses [73,74]. Osteocalcin, a ter-
minal marker of osteoblastic differentiation, is present in
high amounts in the bone matrix. It binds calcium and
inhibits bone growth by inhibiting the activity of trans-
glutaminase [75]. After posttranslational modification
with the addition of carboxylated glutamic acid residues
(gla residues), OC gains a high affinity for hydroxyapatite
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conservation of cells in a late-osteoblast stage of differ-
entiation, with associated prevention of osteocytic differ-
entiation [76] and initiation of the remodeling process of
new bone.
Through interpretation of the results derived from our
study, two kinds of osseointegrations were found. The
first type consists of a predominant collagen protein
matrix construct and a self-limiting mineralization process
through increased expression of osteocalcin, which was
observed in the case of the porous titanium and infiltrated
silicatitanate implants. The second type belongs to HA-
infiltrated titanium, characterized by an early increase in
calcium deposits, with a lesser degree of collagen and
non-collagenous protein synthesis. Both types of osseoin-
tegration have potential applications, however in vivo
studies are required to clarify the most suitable type of im-
plant depending on the site of implantation (considering
the mechanical load and the type of bone in need of re-
pair) as well as the associated pathological conditions such
as osteoporosis. Despite some limitations regarding the
mechanical properties of porous apatite ceramics, the ex-
cellent osteoconductivity of HA coatings and the possibil-
ity of associating bioactive molecules (such as proteins,
aminoacids, antibiotics, growth factors, anticancer and
anti-osteoporosis drugs) to calcium phosphate indicate
the potential advantages of the use of this type of coating
especially in osteopenic bone repair [77,78]. On the other
hand, the osseoinductive properties of SiO2-coated Ti im-
plants (as described in our study) and their ability to pro-
mote angiogenesis and enhance neocartilage formation
[73], can provide other important applications in implan-
tology, especially for repairing bones at sites where mech-
anical strength is of lesser importance.Conclusions
Two types of titanium coatings were comparatively stu-
died with regard to bone regeneration, and they induced
different behaviors of osteoblastic cells. Ti implants infil-
trated with hydroxyapatite (HA) demonstrated an in-
creased capacity to induce early mineralization with a
lower ability to induce cell adhesion and proliferation.
Conversely, the implants infiltrated with SiO2, as well as
porous titanium preserved the attachment and adhesion
of osteoblasts, promoted celldifferentiation and induced
the production of the protein component of the extracel-
lular matrix (collagen and the non-collagenic proteins
osteopontin and osteocalcin). The addition of growth fac-
tors BMP-2 and TGFβ1 in the differentiation medium did
not improve the mineralization process. Both types of
coatings have their advantages and limitations, which can
be exploited depending on the local conditions and on the
bone lesions in need of repair. Their properties can beimproved through methods of functionalization with bio-
molecules involved in osteogenesis.
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